Genetix Appoints Dr. Stephen Game as Head of Research and Development
September 29, 2008
New Milton, UK, 29 September 2008 – Genetix Group plc (AIM: GTX) (“Genetix” or the “Company”), the cancer diagnostic and biopharmaceutical technologies group, today announces the appointment of Dr. Stephen Game as Head of Research and Development, a newly created position aimed at further strengthening the Company’s focus on innovation, with effect from 3rd November [...]
September 26, 2008
Tecan, a global leader in laboratory automation and detection, has been granted Transcreener® Far Red FP validated status for its high-end multimode readers Infinite® M1000, Infinite F500 and Safire2™, by BellBrookLabs, LLC, a R&D-driven company and provider of enabling drug discovery screening tools for the pharmaceutical industry. All of Tecan’s high-end multimode microplate readers outlined [...]
September 26, 2008
- Development of next generation of High-Throughput Screening to accelerate the drug discovery process - Paris, September 26, 2008 - Sanofi-aventis announced today the launch of the dScreen Consortium, a research initiative conducted with RainDance Technologies , Inc., Lexington, Massachusetts, and Louis Pasteur University, Strasbourg, France, to develop the next generation of High-Throughput Screening (HTS) [...]
Fluidigm Withdraws Its Registration Statement for Initial Public Offering
September 26, 2008
Fluidigm Corporation today announced that due to the historic instability in the market, the company is withdrawing its registration statement for its initial public offering of shares of common stock. "We went out on September 5th with a very strong story and Fluidigm received a warm reception from the investment community. We explained how our [...]
RainDance Dedicates New Headquarters, Manufacturing Facility
September 26, 2008
LEXINGTON, Mass., Sept. 26 -- RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, today dedicated its new headquarters and operations building and unveiled its new RDT 1000 instrument. Keynoting the event was Sir Richard Roberts, 2003 Nobel Prize winner for physiology and medicine and Founder and Chief [...]
September 26, 2008
- Custom Chiral Separation Using Preparative Chromatography Eases and Speeds up Process Development; Rapidly and Efficiently Producing the Required Amount of Compounds for Early Development Phases While Being Cost Efficient at Industrial Scale POMPEY, France, September 26 -- Novasep, a global leader in advanced separation technologies, has recently added a state-of-the-art cGMP pilot scale continuous [...]
Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition
September 26, 2008
Invitrogen Corporation (NASDAQ:IVGN) today announced that the syndication of the financing relating to its proposed acquisition of Applied Biosystems announced on June 12, 2008 has been completed. Pricing for the $2.65 billion financing was in line with expected terms. The Term Loan A, in the amount of $1.4 billion, and the Revolving Credit Facility, in [...]
Clarient and Definiens Collaborate to Develop Image Analysis Technology for Cancer Diagnostics
September 25, 2008
Clarient, Inc. (Nasdaq:CLRT) and Definiens, Inc. jointly announced today that they established a strategic partnership to employ a series of image analysis platforms for Clarient's in-house research and development, and Web-based customer portal PATHSiTE(SM). Under a five year collaborative agreement, Clarient and Definiens plan to develop and commercialize tools that will help to evaluate quantitative [...]
September 25, 2008
The Advanced Technology X-Ray System is Currently Being Deployed By TSA at Aviation Checkpoints in the United States HAWTHORNE, Calif.--Rapiscan Systems, Inc., a global leading supplier of security inspection systems, announced today that it has received approval for use from the United Kingdom’s Department for Transport (DfT) for its Rapiscan 620DV (Dual View) X-ray system [...]
September 25, 2008
Affymetrix Inc. (Nasdaq:AFFX) announced today that the Wellcome Trust Sanger Institute has developed a catalog of structural genomic changes in almost 800 cancer cell lines using the company's Genome-Wide Human SNP Array 6.0. Cancer cell lines are invaluable reagents in analyzing the molecular biology of the disease as well as important tools in developing new [...]
